
- Volume 0 0
Regulators Plan New "Electronic Pedigree" to Track Drug Packages
A new high-tech system for trackingprescription drug packages with radiosignals moved a step closer towardimplementation with the establishmentof a blue-ribbon task force ofpharmacists, regulators, and informationtechnology experts responsible forcreating standards for a nationwide Rx"electronic pedigree."
The group was formed by theNational Association of Boards of Pharmacy(NABP) in an effort to forge uniformsoftware standards for the use ofRadio Frequency Identification (RFID)technology to create an electronic"chain of custody record" or "pedigree"for each package of drugs distributedby manufacturers and wholesalersto pharmacies.
According to NABP officials, electronicpedigrees, able to track and tracea drug product from the time it leavesa drug manufacturer until it is dispensedto a patient by a pharmacist,could become a reality nationwidewithin the next few years.
In addition to curbing diversionand assisting in recalls, such an electronicRx-tracking system would alsoprovide state pharmacy boards with avaluable new enforcement tool, NABPofficials said.
FDA officials consider RFID technologyone of the best means to improvethe security of the nation's drug supply,and lawmakers in California andFlorida have already passed legislationto either allow or require e-pedigreesfor intrastate shipments of pharmaceuticalproducts.
Mr. Rankin is a freelance medical writer.
Articles in this issue
over 20 years ago
Issues in the Treatment of Patients with Hypothyroidismover 20 years ago
Health Organizations Favor Electronic Health Recordsover 20 years ago
Therapeutic Management of Bronchitisover 20 years ago
Program Advocates for Timely Prescription Refillsover 20 years ago
Cardinal Backs RFID Technologyover 20 years ago
Agreement Improves Point of Careover 20 years ago
Decision Unpopular with Health Care Professionalsover 20 years ago
The Importance of the Order of Drug Administrationover 20 years ago
Beware of Erroneous Daily Oral Methotrexate Dosing!Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.